Retina

According to Jeffrey Heier, MD, RGX-314 administered by subretinal injection was well tolerated. In addition, it was associated with dose-dependent increase in ocular protein expression and evidence of clinical benefit.

Nieraj Jain, MD, describes the investigations that led to the recent identification of this drug-related retinal toxicity and described the clinical features that support its diagnosis.

Speakers at AAO 2019 event describe journey leading to approval of the first gene therapy for a genetic disease.

Researchers demonstrate the feasibility of a surgical method that specifically targets the area of geographic atrophy for RPE replacement.

Genetic factors play a key role in the onset and progression of diabetic retinopathy, with 65 genes ifentified with several belonging to signaling pathways.